Known targets — ChEMBL curated mechanism
ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | COMT | P21964 | 1/20 | 0.40 |
| ▸ | SNCA | P37840 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17961164 | 0.87 | SMN1; SMN2 (0.52) | KDM4EALDH1A1MAPTTDP1L3MBTL1 | |
| Sulfuric Acid SCHEMBL4250215 | 0.82 | LPO (0.41) | KDM4EALDH1A1HTTTSHRCYP3A4 | |
| Sulfuric Acid SCHEMBL2995711 | 0.82 | LPO (0.41) | KDM4EALDH1A1HTTTSHRCYP3A4 | |
| SCHEMBL5091012 | 0.82 | TSHR (0.54) | KDM4EALDH1A1MAPTTDP1L3MBTL1 | |
| SCHEMBL28367333 | 0.81 | TSHR (0.50) | KDM4EALDH1A1MAPTTDP1L3MBTL1 | |
| SCHEMBL29402099 | 0.81 | TSHR (0.53) | KDM4EALDH1A1MAPTTDP1L3MBTL1 | |
| SCHEMBL3000417 | 0.81 | CA12 (0.42) | KDM4EALDH1A1SMN1; SMN2CYP3A4KMT2A | |
| SCHEMBL2394920 | 0.80 | ALDH1A1 (0.48) | KDM4EALDH1A1MAPTTDP1L3MBTL1 | |
| SCHEMBL7418618 | 0.79 | NMT1 (0.46) | KDM4EALDH1A1MAPTTDP1L3MBTL1 | |
| SCHEMBL1947104 | 0.78 | GAA (0.59) | KDM4EALDH1A1MAPTTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | claimed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | claimed |
| CN-111836849-B | Process for producing fibers, films and moldings of polybenzazole polymer (P) | 巴斯夫欧洲公司 | 2023-04-07 | — | — | CN | disclosed |
| EP-3512905-B1 | METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) | BASF SE (DE) | 2022-08-24 | — | — | EP | disclosed |
| US-20200407508-A1 | METHOD FOR PRODUCING FIBERS, FILMS AND MOLDINGS OF A POLYBENZAZOLE POLYMER (P) | BASF SE (DE) | 2020-12-31 | — | — | US | disclosed |
| EP-3512905-A1 | METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) | BASF SE (DE) | 2019-07-24 | — | — | EP | disclosed |
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | disclosed |
| US-7897806-B2 | Reacting primary amines with phosgene in ionic liquid as solvent | BASF AKTIENGESELLSCHAFT (DE) | 2011-03-01 | — | — | US | disclosed |
| US-20100191010-A1 | PROCESS FOR THE SYNTHESIS OF CARBAMATES USING CO2 | HUNTSMAN INTERNATIONAL LLC (US) | 2010-07-29 | — | — | US | disclosed |
| EP-2173705-A1 | PROCESS FOR THE SYNTHESIS OF CARBAMATES USING CO2 | Huntsman International LLC (US) | 2010-04-14 | — | — | EP | disclosed |
| US-7659430-B2 | Method for separating hydrogen chloride and phosgene | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-09 | — | — | US | disclosed |
| EP-1789160-B1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF SE (DE) | 2009-11-18 | — | — | EP | disclosed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | disclosed |
| WO-2009013062-A1 | PROCESS FOR THE SYNTHESIS OF CARBAMATES USING CO2 | HUNTSMAN INTERNATIONAL LLC (US) | 2009-01-29 | — | — | WO | disclosed |
| EP-2011782-A1 | Process for the synthesis of carbamates using co2 | HUNTSMAN INTERNATIONAL LLC (US) | 2009-01-07 | — | — | EP | disclosed |
| US-20070293707-A1 | Method for Separating Hydrogen Chloride and Phosgene | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | PGLS, INMT, PNMT | KDM4E 3386/4885ALDH1A1 4028/4885MAPT 1739/4885 |
| US-20070293707-A1 | Method for Separating Hydrogen Chloride and Phosgene | PSPH, SLC9B2, HVCN1 | KDM4E 4758/4885ALDH1A1 4716/4885MAPT 4430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.